Transforming Healthcare with Proven Impact At Zenovara Pharmaceuticals, our commitment to innovation extends beyond drug development—we measure success by real-world patient outcomes. 250+ active clinical trials across oncology, neurology, and rare diseases 85% of patients on Nexavion™ reported improved quality of life within 3 months 92% of late-stage trial therapies demonstrate significant efficacy improvements Video